For: | Shepherd EL, Karim S, Newsome PN, Lalor PF. Inhibition of vascular adhesion protein-1 modifies hepatic steatosis in vitro and in vivo. World J Hepatol 2020; 12(11): 931-948 [PMID: 33312420 DOI: 10.4254/wjh.v12.i11.931] |
---|---|
URL: | https://www.wjgnet.com/1948-5182/full/v12/i11/931.htm |
Number | Citing Articles |
1 |
I‐Weng Yen, Hung‐Yuan Li. The role of vascular adhesion protein‐1 in diabetes and diabetic complications. Journal of Diabetes Investigation 2024; 15(8): 982 doi: 10.1111/jdi.14209
|
2 |
Ming Yang, Shuai Liu, Yuxiang Sui, Chunye Zhang. Macrophage metabolism impacts metabolic dysfunction-associated steatotic liver disease and its progression. Immunometabolism 2024; 6(3): e00047 doi: 10.1097/IN9.0000000000000047
|
3 |
Tieshan Teng, Shuai Qiu, Yiming Zhao, Siyuan Zhao, Dequan Sun, Lingzhu Hou, Yihang Li, Ke Zhou, Xixi Yu, Changyong Yang, Yanzhang Li. Pathogenesis and Therapeutic Strategies Related to Non-Alcoholic Fatty Liver Disease. International Journal of Molecular Sciences 2022; 23(14): 7841 doi: 10.3390/ijms23147841
|
4 |
Somaya Albhaisi, Mazen Noureddin. Current and Potential Therapies Targeting Inflammation in NASH. Frontiers in Endocrinology 2021; 12 doi: 10.3389/fendo.2021.767314
|
5 |
Alok D. Singh, Yogesh A. Kulkarni. Vascular adhesion protein-1 and microvascular diabetic complications. Pharmacological Reports 2022; 74(1): 40 doi: 10.1007/s43440-021-00343-y
|
6 |
Liza Dewyse, Hendrik Reynaert, Leo A. van Grunsven. Best Practices and Progress in Precision-Cut Liver Slice Cultures. International Journal of Molecular Sciences 2021; 22(13): 7137 doi: 10.3390/ijms22137137
|
7 |
Rallia-Iliana Velliou, Eirini Giannousi, Christiana Ralliou, Eva Kassi, Antonios Chatzigeorgiou. Ex Vivo Tools and Models in MASLD Research. Cells 2024; 13(22): 1827 doi: 10.3390/cells13221827
|
8 |
Hui Li, Shiyu Du, Panpan Niu, Xiaosong Gu, Jun Wang, Ying Zhao. Vascular Adhesion Protein-1 (VAP-1)/Semicarbazide-Sensitive Amine Oxidase (SSAO): A Potential Therapeutic Target for Atherosclerotic Cardiovascular Diseases. Frontiers in Pharmacology 2021; 12 doi: 10.3389/fphar.2021.679707
|
9 |
Mei Li, Frederik T. Larsen, Marius C. van den Heuvel, Konstanze Gier, Alan R. Gorter, Dorenda Oosterhuis, Johan Bijzet, Vincent E. de Meijer, Kim Ravnskjaer, Anika Nagelkerke, Peter Olinga. Metabolic Dysfunction-Associated Steatotic Liver Disease in a Dish: Human Precision-Cut Liver Slices as a Platform for Drug Screening and Interventions. Nutrients 2024; 16(5): 626 doi: 10.3390/nu16050626
|
10 |
Pietro Torre, Benedetta Maria Motta, Roberta Sciorio, Mario Masarone, Marcello Persico. Inflammation and Fibrogenesis in MAFLD: Role of the Hepatic Immune System. Frontiers in Medicine 2021; 8 doi: 10.3389/fmed.2021.781567
|
11 |
Larisse Longo, Rafael Aguiar Marschner, Laura Bainy Rodrigues de Freitas, Laura Renata de Bona, Luiza Behrens, Matheus Henrique Mariano Pereira, Valessa Emanoele Gabriel de Souza, Luiza Cecília Leonhard, Giulianna Zanettini, Carlos Eduardo Pinzon, Guilherme Jorge Semmelmann Pereira Lima, Carlos Thadeu Schmidt Cerski, Carolina Uribe-Cruz, Simone Magagnin Wajner, Mário Reis Álvares-da-Silva. Redefining the Role of Ornithine Aspartate and Vitamin E in Metabolic-Dysfunction-Associated Steatotic Liver Disease through Its Biochemical Properties. International Journal of Molecular Sciences 2024; 25(13): 6839 doi: 10.3390/ijms25136839
|